Published in Lancet on November 02, 1996
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut (2000) 2.16
KASL Clinical Practice Guidelines: Management of chronic hepatitis B. Clin Mol Hepatol (2012) 2.10
Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus. Antimicrob Agents Chemother (1997) 1.94
Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int (2015) 1.92
Inhibition of human hepatitis B virus replication by AT-61, a phenylpropenamide derivative, alone and in combination with (-)beta-L-2',3'-dideoxy-3'-thiacytidine. Antimicrob Agents Chemother (1998) 1.21
Hepatitis B reactivation after chemotherapy: two decades of clinical research. Hepatol Int (2008) 1.13
The M539V polymerase variant of human hepatitis B virus demonstrates resistance to 2'-deoxy-3'-thiacytidine and a reduced ability to synthesize viral DNA. Antimicrob Agents Chemother (1998) 1.09
Use of the hepatitis B virus recombinant baculovirus-HepG2 system to study the effects of (-)-beta-2',3'-dideoxy-3'-thiacytidine on replication of hepatitis B virus and accumulation of covalently closed circular DNA. Antimicrob Agents Chemother (1999) 1.05
New era of liver transplantation for hepatitis B: a 17-year single-center experience. Ann Surg (2002) 0.91
Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis. Ann Surg (2001) 0.89
Outcome of orthotopic liver transplantation in patients with haemophilia. Gut (1998) 0.89
Comparison of three different sensitive assays for hepatitis B virus DNA in monitoring of responses to antiviral therapy. J Clin Microbiol (2000) 0.89
The intracellular activation of lamivudine (3TC) and determination of 2'-deoxycytidine-5'-triphosphate (dCTP) pools in the presence and absence of various drugs in HepG2 cells. Br J Clin Pharmacol (2000) 0.89
Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann Surg (1998) 0.88
Serum hepatitis B virus DNA before liver transplantation correlates with HBV reinfection rate even under successful low-dose hepatitis B immunoglobulin prophylaxis. Hepatol Int (2011) 0.87
Which patients respond best to hepatitis B vaccination after a hepatitis B virus-related liver transplantation? J Gastroenterol (2013) 0.86
Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut (1999) 0.85
Chronic hepatitis B in 2014: great therapeutic progress, large diagnostic deficit. World J Gastroenterol (2014) 0.83
Update on chronic viral hepatitis. Postgrad Med J (2001) 0.83
Management of HBV Infection in Liver Transplantation Patients. Int J Med Sci (2005) 0.81
Is hepatitis B immunoglobulin necessary in prophylaxis of hepatitis B recurrence after liver transplantation? A meta-analysis. PLoS One (2014) 0.81
Treatment options for chronic hepatitis. Antivirals look promising. BMJ (1999) 0.81
Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues. Ann Clin Microbiol Antimicrob (2006) 0.81
Liver transplantation for viral hepatitis in 2015. World J Gastroenterol (2016) 0.80
Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant. Ann Surg (1997) 0.80
Hepatitis B and liver transplantation: molecular and clinical features that influence recurrence and outcome. World J Gastroenterol (2014) 0.79
Hepatitis B virus infection and renal transplantation. World J Gastroenterol (2010) 0.79
Safe and cost-effective control of post-transplantation recurrence of hepatitis B. Hepatol Res (2014) 0.79
Current prophylactic strategies against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol (2009) 0.78
Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening. Antimicrob Agents Chemother (2003) 0.77
Change of strategies and future perspectives against hepatitis B virus recurrence after liver transplantation. World J Gastroenterol (2015) 0.76
Prophylaxis against hepatitis B virus recurrence after liver transplantation: a registry study. World J Gastroenterol (2015) 0.76
Management of chronic hepatitis B before and after liver transplantation. World J Hepatol (2015) 0.76
Therapy of Delta Hepatitis. Cold Spring Harb Perspect Med (2015) 0.76
Organ transplantation and discrimination. Treatment should be available to everyone. BMJ (2000) 0.75
Prophylactic managements of hepatitis B viral infection in liver transplantation. World J Gastroenterol (2016) 0.75
Rational Basis for Optimizing Short and Long-term Hepatitis B Virus Prophylaxis Post Liver Transplantation: Role of Hepatitis B Immune Globulin. Transplantation (2015) 0.75
Hepatitis B virus infection in liver transplant candidates and recipients. MedGenMed (2005) 0.75
Update in liver transplantation. Can Fam Physician (1999) 0.75
Long term outcome of liver transplantation for viral hepatitis: is there a need to re-evaluate patient selection? Gut (1999) 0.75
Effectiveness of lamivudine in treatment of acute recurrent hepatitis B after liver transplantation. Dig Dis Sci (1998) 0.75
The relationship between HBcrAg and HBV reinfection in HBV related post-liver transplantation patients. J Gastroenterol (2016) 0.75
Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature (1998) 60.62
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
The genome sequence of Schizosaccharomyces pombe. Nature (2002) 14.26
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet (1979) 12.29
Massive gene decay in the leprosy bacillus. Nature (2001) 11.98
Complete DNA sequence of a serogroup A strain of Neisseria meningitidis Z2491. Nature (2000) 9.86
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
A BASIC MECHANISM IN THE BIOLOGICAL EFFECTS OF TEMPERATURE, PRESSURE AND NARCOTICS. Science (1942) 8.76
Degradation of polychlorinated biphenyls by two species of Achromobacter. Can J Microbiol (1973) 7.70
The normal kidney filters nephrotic levels of albumin retrieved by proximal tubule cells: retrieval is disrupted in nephrotic states. Kidney Int (2007) 6.99
Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet (1979) 6.10
Interactions between saturated acyl chains confer detergent resistance on lipids and glycosylphosphatidylinositol (GPI)-anchored proteins: GPI-anchored proteins in liposomes and cells show similar behavior. Proc Natl Acad Sci U S A (1994) 5.61
Measurement of instantaneous left ventricular dimension and filling rate in man, using echocardiography. Br Heart J (1973) 5.61
Carcinoid tumour. Lancet (1998) 4.52
Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort. Aliment Pharmacol Ther (2014) 3.98
Regulation of cardiac mesodermal and neural crest development by the bHLH transcription factor, dHAND. Nat Genet (1997) 3.89
COX 2 inhibitor and fulminant hepatic failure. Lancet (1999) 3.80
Reduced naphthylphthalamic acid binding in the tir3 mutant of Arabidopsis is associated with a reduction in polar auxin transport and diverse morphological defects. Plant Cell (1997) 3.78
Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J Infect Dis (1981) 3.76
The complete nucleotide sequence of chromosome 3 of Plasmodium falciparum. Nature (1999) 3.44
Diagnostic importance of changes in circulating concentrations of immunoreactive trypsin. Lancet (1977) 3.43
Good clinical outcomes following transjugular intrahepatic portosystemic stent-shunts in Budd-Chiari syndrome. Aliment Pharmacol Ther (2014) 3.39
The human kidney low affinity Na+/glucose cotransporter SGLT2. Delineation of the major renal reabsorptive mechanism for D-glucose. J Clin Invest (1994) 3.30
Improved survival after orthotopic liver grafting. Br Med J (Clin Res Ed) (1981) 3.09
Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg (1988) 3.04
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology (1996) 2.99
Use of partial cardiopulmonary bypass during the anhepatic phase of orthotopic liver grafting. Lancet (1979) 2.98
The use of corticosteroids in the treatment of acute asthma. Q J Med (1975) 2.95
Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation (2000) 2.90
Sequence variability in the 5' non-coding region of hepatitis C virus: identification of a new virus type and restrictions on sequence diversity. J Gen Virol (1993) 2.87
The use of swift, brief isolation as a group control device for institutionalized delinquents. Behav Res Ther (1967) 2.85
Search for a resonance decaying into WZ boson pairs in pp collisions. Phys Rev Lett (2010) 2.83
Regression of murine lung tumors by the let-7 microRNA. Oncogene (2009) 2.83
Physical activity social support and middle- and older-aged minority women: results from a US survey. Soc Sci Med (1999) 2.79
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC. Cancer Treat Rev (2007) 2.75
Comparative effectiveness of full-length and B-domain deleted factor VIII for prophylaxis--a meta-analysis. Haemophilia (2003) 2.72
Measles vaccination and antibody response in autism spectrum disorders. Arch Dis Child (2008) 2.71
Cyclosporin A in cadaveric organ transplantation. Br Med J (Clin Res Ed) (1981) 2.67
Correlates of HIV infection among young adult short-term injection drug users. AIDS (2000) 2.63
Preconditioning of human myocardium with adenosine during coronary angioplasty. Circulation (1997) 2.60
Hepatitis C virus genotypes: an investigation of type-specific differences in geographic origin and disease. Hepatology (1994) 2.60
Post-marketing surveillance of enalapril: experience in 11,710 hypertensive patients in general practice. J R Coll Gen Pract (1987) 2.57
Prolonged survival of pig orthotopic heart grafts treated with cyclosporin A. Lancet (1978) 2.57
Localization of MIWC and GLIP water channel homologs in neuromuscular, epithelial and glandular tissues. J Cell Sci (1995) 2.55
Elastography for the diagnosis of severity of fibrosis in chronic liver disease: a meta-analysis of diagnostic accuracy. J Hepatol (2010) 2.50
Heterogeneous distribution of filipin--cholesterol complexes across the cisternae of the Golgi apparatus. Proc Natl Acad Sci U S A (1981) 2.45
Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms. Hepatology (2000) 2.45
On the molecular basis and regulation of cellular capacitative calcium entry: roles for Trp proteins. Proc Natl Acad Sci U S A (1996) 2.44
Cholangiography in the jaundiced patient. Gut (1976) 2.44
Anti-tuberculosis medication and the liver: dangers and recommendations in management. Eur Respir J (1995) 2.39
Antibody to herpes simplex virus type 2 as a marker of sexual risk behavior in rural Tanzania. J Infect Dis (1999) 2.37
Medical evacuation from Mostar. Lancet (1996) 2.37
Bacterial infection in the pathogenesis of variceal bleeding. Lancet (1999) 2.35
New developments in the Life Table Analysis System of the National Institute for Occupational Safety and Health. J Occup Med (1990) 2.33
The epidemiology of measles in England and Wales: rationale for the 1994 national vaccination campaign. Commun Dis Rep CDR Rev (1994) 2.32
Consistent patterns of expression of HLA class I free heavy chains in healthy individuals and raised expression in spondyloarthropathy patients point to physiological and pathological roles. Rheumatology (Oxford) (2006) 2.31
The Eurotransplant donor risk index in liver transplantation: ET-DRI. Am J Transplant (2012) 2.29
Comparison of several equations and derivation of a new equation for calculating basal metabolic rate in obese children. J Am Coll Nutr (1998) 2.27
A randomized trial of percutaneous transhepatic cholangiography with the Chiba needle versus endoscopic retrograde cholangiography for bile duct visualization in jaundice. Gastroenterology (1976) 2.25
Protein kinase A phosphorylation is involved in regulated exocytosis of aquaporin-2 in transfected LLC-PK1 cells. Am J Physiol (1997) 2.23
An evaluation of emergency sclerotherapy of varices in randomized trials: looking the needle in the eye. Endoscopy (2006) 2.22
Coagulation and fibrosis in chronic liver disease. Gut (2008) 2.22
Selective decontamination of the digestive tract reduces gram-negative pulmonary colonization but not systemic endotoxemia in patients undergoing elective liver transplantation. Crit Care Med (1994) 2.21
Significance of systemic endotoxaemia in inflammatory bowel disease. Gut (1995) 2.21
Directional instability of microtubule transport in the presence of kinesin and dynein, two opposite polarity motor proteins. J Cell Biol (1992) 2.20
Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer. J Clin Oncol (2001) 2.18
Localization of the CHIP28 water channel in rat kidney. Am J Physiol (1992) 2.17
Outcome of lamivudine resistant hepatitis B virus infection in the liver transplant recipient. Gut (2000) 2.16
The mercurial insensitive water channel (AQP-4) forms orthogonal arrays in stably transfected Chinese hamster ovary cells. J Biol Chem (1996) 2.16
Clinical profile and outcome of swine flu in Indian children. Indian Pediatr (2010) 2.14
Systematic review and meta-analysis of intraoperative versus preoperative endoscopic sphincterotomy in patients with gallbladder and suspected common bile duct stones. Br J Surg (2011) 2.13
Effects of temperature on Vitalograph spirometer readings. Thorax (1983) 2.13
Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis (2008) 2.12
Paralytic poliomyelitis in England and Wales, 1985-91. BMJ (1992) 2.11
Controlled trial of propranolol for the prevention of recurrent variceal hemorrhage in patients with cirrhosis. N Engl J Med (1983) 2.10
Serum trypsin concentrations in diabetes mellitus. Br Med J (1978) 2.09
Epidemiology of antibiotic-associated colitis; isolation of Clostridium difficile from the hospital environment. Am J Med (1981) 2.08
Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1- and CR3-dependent adhesion events. J Immunol (1992) 2.05
Viability and functional activity of cryopreserved mononuclear cells. Clin Diagn Lab Immunol (2000) 2.05
Minocycline induced autoimmune hepatitis and systemic lupus erythematosus-like syndrome. BMJ (1996) 2.04
Multicentre survey of radiologically inserted gastrostomy feeding tube (RIG) in the UK. Clin Radiol (2012) 2.04
Liver glucose transporter: a basolateral protein in hepatocytes and intestine and kidney cells. Am J Physiol (1990) 2.03
Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses. Euro Surveill (2009) 2.01
Risk factors, sequential organ failure assessment and model for end-stage liver disease scores for predicting short term mortality in cirrhotic patients admitted to intensive care unit. Aliment Pharmacol Ther (2006) 2.00
The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat (2011) 2.00
Caveolin-2 localizes to the golgi complex but redistributes to plasma membrane, caveolae, and rafts when co-expressed with caveolin-1. J Biol Chem (1999) 2.00
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study. Lancet (2000) 1.99
Human CD1d-glycolipid tetramers generated by in vitro oxidative refolding chromatography. Proc Natl Acad Sci U S A (2001) 1.99
Scleraxis: a basic helix-loop-helix protein that prefigures skeletal formation during mouse embryogenesis. Development (1995) 1.99
Hospital admissions attributable to rotavirus infection in England and Wales. J Infect Dis (1996) 1.98
Randomised controlled trials of ursodeoxycholic-acid therapy for primary biliary cirrhosis: a meta-analysis. Lancet (1999) 1.98
Culture of preimplantation mouse embryos affects fetal development and the expression of imprinted genes. Biol Reprod (2001) 1.97